|
業務類別
|
Biotechnology |
|
業務概覽
|
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services. |
| 公司地址
| 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 858 546-0004 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.maravai.com |
| 員工數量
| 435 |
| Mr. Bernd Brust |
Director and Chief Executive Officer |
美元 388.86K |
24/04/2026 |
| Mr. Rajesh J. Asarpota |
Chief Financial Officer and Principal Accounting Officer |
美元 253.37K |
24/04/2026 |
| Ms. Christine Dolan |
Executive Vice President and General Manager, Cygnus Technologies |
美元 450.97K |
24/04/2026 |
| Mr. Kurt Oreshack |
Executive Vice President, General Counsel and Secretary |
美元 455.44K |
24/04/2026 |
|
|
| Mr. Bernd Brust |
Director and Chief Executive Officer |
24/04/2026 |
| Mr. Gregory T. Lucier |
Independent Director |
24/04/2026 |
| Dr. John A. DeFord, PhD |
Independent Director |
24/04/2026 |
| Mr. Sean L. Cunningham |
Director |
24/04/2026 |
| Mr. Constantine S. Mihas |
Director |
24/04/2026 |
| Ms. Susannah Gray, M.B.A. |
Independent Director |
24/04/2026 |
| Mr. Luke Marker |
Director |
24/04/2026 |
| Mr. Robert Andrew Eckert |
Chairman of the Board |
24/04/2026 |
|
|
|
|
